Press Release from FDA, Released on 09/20/2013
Today, the U.S. Food and Drug Administration announced a
final rule for the unique device identification system (UDI) that, once implemented, will provide a consistent way to identify medical devices.
The UDI system has the potential to improve the quality of information in medical device adverse events reports, which will help the FDA identify product problems more quickly, better target recalls, and improve patient safety. The FDA has worked closely with industry, the clinical community and patient and consumer groups in the development of this rule.
“UDI represents a landmark step in improving patient safety, modernizing our postmarket surveillance system for medical devices, and facilitating medical device innovation,” said Jeffrey Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health.
The UDI system consists of two core items. The first is a unique number assigned by the device manufacturer to the version or model of a device, called a unique device identifier. This identifier will also include production-specific information such as the product’s lot or batch number, expiration date, and manufacturing date when that information appears on the label…. [
Read More ]
Related Event
When: Tuesday, November 05 to Wednesday, November 06, 2013
Where: Millennium Knickerbocker Hotel, Chicago, IL
To Learn More, Visit:
www.americanconference.com/fdabootcamp-devices
For a complete list of upcoming Pharma events:
Click Here
For a list of past Pharma related conference proceedings:
Click Here
Tags: FDA, FDA Devices, Legal News, Pharma